Cetera Advisor Networks LLC Ironwood Pharmaceuticals Inc Transaction History

Cetera Advisor Networks LLC

  • $0
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$10.37 - $12.56 $1,503 - $1,821
-145 Reduced 1.28%
11,213 $117,000
Q4 2022

Feb 14, 2023
SELL
$9.9 - $12.43 $10,375 - $13,026
-1,048 Reduced 8.45%
11,358 $140,000
Q3 2022

Nov 10, 2022
BUY
$10.14 - $12.38 $14,043 - $17,146
1,385 Added 12.57%
12,406 $129,000
Q1 2022

May 12, 2022
BUY
$10.61 - $12.88 $9,474 - $11,501
893 Added 8.82%
11,021 $139,000
Q4 2021

Feb 14, 2022
BUY
$10.86 - $13.95 $109,990 - $141,285
10,128 New
10,128 $118,000

Others Institutions Holding IRWD

# of Institutions
231
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $570M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email